High-Level Gait Disorder: Associations with Specific White Matter Changes Observed on Advanced Diffusion Imaging

Journal of Neuroimaging

Volumn 23, Issue 1, 2013, Pages 39-46

  Kafri, Michal ^a   Sasson, Efrat ^a,b   Assaf, Yaniv ^a,b   Balash, Yaacov ^a,b   Aiznstein, Orna ^a   Hausdorff, Jeffrey M ^a,b   Giladi, Nir ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aging; Diffusion tensor imaging; Gait; Q space imaging; White matter

Indexed keywords

AMANTADINE; LEVODOPA; MEMANTINE; RASAGILINE; RIVASTIGMINE;

AGED; ARTICLE; CEREBRAL PEDUNCLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; GAIT DISORDER; HIGH LEVEL GAIT DISORDER; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PYRAMIDAL TRACT; SUPERIOR CEREBELLAR PEDUNCLE; THALAMUS; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALGORITHMS; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; NERVE FIBERS, MYELINATED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84872603328     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2012.00734.x     Document Type: Article

References (54)

1. Sudarsky L. Gait disorders: prevalence, morbidity, and etiology. Adv Neurol 2001;87:111-117.
2. Thompson PD, Nutt JG. Higher level gait disorders. J Neural Transm 2007;114:1305-1307.
3. Snijders AH, van de Warrenburg BP, Giladi N, et al. Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol 2007;6:63-74.
4. Nutt J, Marsden C, Thompson P. Human walking and higher-level gait disorders, particularly in the elderly. Neurology 1993;43:268-279.
5. Herman T, Giladi N, Gurevich T, et al. Gait instability and fractal dynamics of older adults with a "cautious" gait: why do certain older adults walk fearfully? Gait Posture 2005;21:178-185.
6. Giladi N, Herman T, Reider-Groswasser I, et al. Clinical characteristics of elderly patients with a cautious gait of unknown origin. J Neurol 2005;252:300-306.
7. Franch O, Calandre L, Alvarez-Linera J, et al. Gait disorders of unknown cause in the elderly: clinical and MRI findings. J Neurol Sci 2009;280:84-86.
8. Baloh R, Vinters H. White matter lesions and disequilibrium in older people. II. Clinicopathologic correlation. Arch Neurol 1995;52:975-981.
9. Benson R, Guttmann C, Wei X, et al. Older people with impaired mobility have specific loci of periventricular abnormality on MRI. Neurology 2002;58:48-55.
10. Camicioli R, Moore M, Sexton G, et al. Age-related brain changes associated with motor function in healthy older people. J Am Geriatr Soc 1999;47:330-334.
11. Guttmann C, Benson R, Warfield S, et al. White matter abnormalities in mobility-impaired older persons. Neurology 2000;54:1277-1283.
12. Whitman G, DiPatre P, Lopez I, et al. Neuropathology in older people with disequilibrium of unknown cause. Neurology 1999;53:375-382.
13. Whitman G, Tang Y, Lin A, et al. A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 2001;57:990-994.
14. Wolfson L, Wei X, Hall C, et al. Accrual of MRI white matter abnormalities in elderly with normal and impaired mobility. J Neurol Sci 2005;232:23-27.
15. Tell G, Lefkowitz D, Diehr P, et al. Relationship between balance and abnormalities in cerebral magnetic resonance imaging in older adults. Arch Neurol 1998;55:73-79.
16. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689-701.
17. Zhang AJ, Yu XJ, Wang M. The clinical manifestations and pathophysiology of cerebral small vessel disease. Neurosci Bull 2010;26:257-264.
18. Martin MP, O'Neill D. Vascular higher-level gait disorders-a step in the right direction? Lancet 2004;363:8.
19. Liston R, Mickelborough J, Bene J, et al. A new classification of higher level gait disorders in patients with cerebral multi-infarct states. Age Ageing 2003;32:252-258.
20. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996;111:209-219.
21. Basser PJ, Pierpaoli C. A simplified method to measure the diffusion tensor from seven MR images. Magn Reson Med 1998;39:928-934.
22. Assaf Y, Cohen Y. Assignment of the water slow-diffusing component in the central nervous system using q-space diffusion MRS: implications for fiber tract imaging. Magn Reson Med 2000;43:191-199.
23. Assaf Y, Mayk A, Cohen Y. Displacement imaging of spinal cord using q-space diffusion-weighted MRI. Magn Reson Med 2000;44:713-722.
24. Horsfield MA, Jones DK. Applications of diffusion-weighted and diffusion tensor MRI to white matter diseases-a review. NMR Biomed 2002;15:570-577.
25. O'Sullivan M, Morris RG, Huckstep B, et al. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatr 2004;75:441-447.
26. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Roentgenol 1987;149:351-356.
27. Pantoni L, Basile AM, Pracucci G, et al. Impact of age-related cerebral white matter changes on the transition to disability-the LADIS study: rationale, design and methodology. Neuroepidemiology 2005;24:51-62.
28. Assaf Y, Mayk A, Eliash S, et al. Hypertension and neuronal degeneration in excised rat spinal cord studied by high-b value q-space diffusion magnetic resonance imaging. Exp Neurol 2003;184:726-736.
29. Assaf Y, Kafri M, Shinar H, et al. Changes in axonal morphology in experimental autoimmune neuritis as studied by high b-value q-space (1)H and (2)H DQF diffusion magnetic resonance spectroscopy. Magn Reson Med 2002;48:71-81.
30. Huber-Mahlin V, Giladi N, et al. Progressive nature of a higher level gait disorder: a 3-year prospective study. J Neurol 2010;257:1279-1286.
31. Kandel ER, Schwartz JH, Jessell TM. Principles of Neural Science 4th ed. New York : McGraw-Hill, Health Professions Division; 2000.
32. Sullivan EV, Zahr NM, Rohlfing T, et al. Fiber tracking functionally distinct components of the internal capsule. Neuropsychologia 2010;48:4155-4163.
33. Schmahmann JD. Vascular syndromes of the thalamus. Stroke 2003;34:2264-2278.
34. Schmahmann JD, Pandya DN. Disconnection syndromes of basal ganglia, thalamus, and cerebrocerebellar systems. Cortex 2008;44:1037-1066.
35. Chao YP, Cho KH, Yeh CH, et al. Probabilistic topography of human corpus callosum using cytoarchitectural parcellation and high angular resolution diffusion imaging tractography. Hum Brain Mapp 2009;30:3172-3187.
36. Jokinen H, Ryberg C, Kalska H, et al. Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS Study. J Neurol Neurosurg Psychiatr 2007;78:491-496.
37. Jokinen H, Frederiksen KS, Garde E, et al. Callosal tissue loss parallels subtle decline in psychomotor speed. A longitudinal quantitative MRI study. The LADIS Study. Neuropsychologia 2012;50(7):1650-1655.
38. Schmahmann JD. From movement to thought: anatomic substrates of the cerebellar contribution to cognitive processing. Hum Brain Mapp 1996;4:174-198.
39. Schmahmann JD, Pandya DN. The cerebrocerebellar system. Int Rev Neurobiol 1997;41:31-60.
40. Giladi N, Huber-Mahlin V, Herman T, et al. Freezing of gait in older adults with high level gait disorders: association with impaired executive function. J Neural Transm 2007;114:1349-1353.
41. Seidler RD, Bernard JA, Burutolu TB, et al. Motor control and aging: links to age-related brain structural, functional, and biochemical effects. Neurosci Biobehav Rev 2010;34:721-733.
42. Van Den Heuvel DM, ten Dam VH, de Craen AJ, et al. Measuring longitudinal white matter changes: comparison of a visual rating scale with a volumetric measurement. Am J Neuroradiol 2006;27:875-878.
43. van Straaten EC, Fazekas F, Rostrup E, et al. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 2006;37(3):836-840.
44. Pierpaoli C, Basser PJ. Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 1996;36:893-906.
45. Beaulieu C. The basis of anisotropic water diffusion in the nervous system- a technical review. NMR Biomed 2002;15:435-455.
46. Assaf Y, Pasternak O. Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review. J Mol Neurosci 2008;34:51-61.
47. Farrell JA, Zhang J, Jones MV, et al. q-space and conventional diffusion imaging of axon and myelin damage in the rat spinal cord after axotomy. Magn Reson Med 2010;63:1323-1335.
48. Klawiter EC, Schmidt RE, Trinkaus K, et al. Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords. Neuroimage 2011;55:1454-1460.
49. Sun SW, Liang HF, Cross AH, et al. Evolving Wallerian degeneration after transient retinal ischemia in mice characterized by diffusion tensor imaging. Neuroimage 2008;40:1-10.
50. Assaf Y, Ben-Bashat D, Chapman J, et al. High b-value q-space analyzed diffusion-weighted MRI: application to multiple sclerosis. Magn Reson Med 2002;47:115-126.
51. Assaf Y, Chapman J, Ben-Bashat D, et al. White matter changes in multiple sclerosis: correlation of q-space diffusion MRI and 1H MRS. Magn Reson Imag 2005;23:703-710.
52. Biton IE, Mayk A, Kidron D, et al. Improved detectability of experimental allergic encephalomyelitis in excised swine spinal cords by high b-value q-space DWI. Exp Neurol 2005;195:437-446.
53. Assaf Y, Mayzel-Oreg O, Gigi A, et al. High b value q-space-analyzed diffusion MRI in vascular dementia: a preliminary study. J Neurol Sci 2002;203-204:235-239.
54. Bar-Shir A, Duncan ID, Cohen Y. QSI and DTI of excised brains of the myelin-deficient rat. Neuroimage 2009;48:109-116.